9781632412072 t fc

ISBN : 9781632412072

Publisher :   haylemedical

Language :   English

Category :   Infectious Diseases

Publication Year :   2015

Price : USD 155.00

Description :  This book provides advanced information regarding the constant endeavors being made against the drug resistant characteristics of tuberculosis infection which have posed a serious challenge in treatment against this fatal disease. A strain of Streptomyces Mediterranei (ME-83) - a Streptomyces species - was first extracted from a soil sample in a ranch of pines close to Saint Raphael, France, and isolated in Lepetit Research Labs in the year 1957. This drug became the backbone for chemotherapy with Streptomycin. The wave of happiness generated by the success of this regimen led to the idea that TB eradication would be achievable by 2000s. This was the reason why any further drug enhancements for fighting TB were ceased. However, the lack of a precise administration of these drugs has led to an irruption in the drug resistance of Mycobacterium Tuberculosis. With the declaration of global emergency in 1993, pursuit for new drugs became crucial. Authors from across the globe have contributed in this book with emphasis on the enhancement and activities of novel drug families.

Author/Editor :  Morris Beckler

Author's Description :  Morris Beckler received his MD from the University of Chicago, United States. He specializes in the diagnosis and management of patients with tuberculosis. He spent more than 6 years in the study of molecular and cellular biology of tuberculosis. His work in the field of infectious diseases and bacterial diseases has won him awards and acclaims from the experts in medical industry. Beckler has authored and edited numerous articles, journal papers and books, which have been published worldwide.